NOX4 and pulmonary fibrosis: Pirfenidone has also been reported to attenuate experimental lung fibrosis through the reduction of reactive oxygen species (ROS) generation by downregulating Nox4 expression and improving the expression of antioxidant enzymes such as superoxide dismutase (SOD), catalase and glutathione peroxidase (GPx1) [100,101].